GO:0070328 triglyceride homeostasis: Lipid Storage and Mobilization, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070328 (triglyceride homeostasis) describes the biological process that keeps cellular and organismal triglyceride levels within a physiological range by balancing triglyceride synthesis (esterification) and triglyceride breakdown (lipolysis).
• Triglycerides are stored in lipid droplets, and the dynamic turnover of these organelles is central to triglyceride homeostasis.
• Key regulators include adipose triglyceride lipase (PNPLA2/ATGL), angiopoietin-like 3 (ANGPTL3), the farnesoid X receptor (NR1H4/FXR), ORP8 (OSBPL8), Rab30, and lipopolysaccharide binding protein (LBP).
• Disruption of triglyceride homeostasis contributes to metabolic disorders such as hepatic steatosis, insulin resistance, diabetes, and diabetic nephropathy.
• The triglyceride-glucose (TyG) index is a validated surrogate marker of insulin resistance and a predictor of diabetic nephropathy.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes implicated in triglyceride homeostasis.
Description
Triglyceride homeostasis (GO:0070328) is the biological process that maintains the concentration of triglycerides within a physiological range in cells and organisms. Triglycerides are neutral lipids composed of a glycerol backbone esterified to three fatty acids; they serve as the principal energy storage form and are mobilized during fasting or increased energy demand. Because both excessive and insufficient triglyceride stores are detrimental, cells have evolved tightly regulated pathways for triglyceride synthesis, packaging into lipid droplets, and hydrolysis. Understanding this process is fundamental to metabolic physiology and to diseases such as hepatic steatosis, insulin resistance, and diabetes. Research on triglyceride homeostasis spans molecular enzymology, organelle biology, and whole-body metabolism. The identification of an alternative triglyceride biosynthesis pathway highlighted that multiple routes can contribute to triglyceride production, expanding the set of potential therapeutic targets. Transgenic mouse studies have demonstrated that adipose triglyceride lipase (ATGL/PNPLA2) is a rate-limiting enzyme for triglyceride hydrolysis and is essential for lipid and glucose homeostasis. More recently, proteins such as ORP8 (OSBPL8) and Rab30 have been shown to regulate lipid droplet turnover and lipid homeostasis during fasting, respectively. For researchers, GO:0070328 provides a structured framework to annotate genes, interpret omics data, and design experiments that test causal roles of candidate regulators. This article summarizes the definition, mechanisms, key genes, disease links, and research methods relevant to triglyceride homeostasis, with all factual claims supported by the cited literature-.
triglyceride homeostasis At A Glance
| GO ID | GO:0070328 |
|---|---|
| GO term | triglyceride homeostasis |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Maintains physiological triglyceride levels by balancing synthesis, storage, and lipolysis |
| Key organelles | Lipid droplets, endoplasmic reticulum, cytoplasm |
| Representative regulators | PNPLA2 (ATGL), ANGPTL3, NR1H4 (FXR), OSBPL8 (ORP8), Rab30, LBP |
| Associated diseases | Hepatic steatosis, insulin resistance, diabetes, diabetic nephropathy |
| Research methods | CRISPR KO/KI, lipidomics, live-cell imaging, transgenic models |
What Is GO:0070328?
Triglyceride homeostasis (GO:0070328) is the biological process by which a cell or organism maintains the amount of triglyceride within a normal, functional range. It encompasses the coordinated regulation of triglyceride synthesis (esterification of fatty acids to glycerol), storage in lipid droplets, and hydrolysis (lipolysis) to release fatty acids for energy production or signaling. This process is dynamic and responds to nutritional status, hormonal signals, and cellular stress.
Why Is triglyceride homeostasis Important in Cell Biology?
Triglyceride homeostasis is central to energy metabolism and metabolic health. When this process is dysregulated, triglycerides accumulate excessively in tissues such as liver and adipose, contributing to steatosis, insulin resistance, and type 2 diabetes. Conversely, impaired triglyceride storage or excessive lipolysis can lead to lipotoxicity and metabolic stress. Because triglyceride metabolism intersects with glucose homeostasis, markers such as the triglyceride-glucose index are used clinically to predict insulin resistance and diabetic complications. Thus, understanding GO:0070328 informs both basic physiology and therapeutic strategies for metabolic disease.
• Maintains energy balance by storing excess fatty acids as triglycerides and mobilizing them during fasting.
• Prevents lipotoxicity by safely packaging fatty acids into lipid droplets.
• Regulates glucose homeostasis; ATGL deficiency alters both lipid and glucose metabolism in mice.
• ANGPTL3 inhibition lowers plasma triglycerides and may improve glucose homeostasis.
• FXR (NR1H4) acts as a master regulator of hepatic triglyceride and glucose homeostasis.
• ORP8-mediated lipophagy controls lipid droplet turnover, linking autophagy to triglyceride homeostasis.
• Rab30 facilitates lipid homeostasis during fasting, highlighting fasting-responsive regulation.
• LBP protects against hepatic oxidative stress by regulating lipid droplet homeostasis.
• The TyG index, derived from triglyceride and glucose levels, predicts diabetic nephropathy.
• Alternative triglyceride biosynthesis pathways provide backup routes that can be targeted in disease.
What Happens During triglyceride homeostasis?
Triglyceride Synthesis (Esterification)
In simple terms: The cell builds triglycerides by attaching fatty acids to a glycerol backbone.
Triglyceride synthesis occurs through the sequential esterification of fatty acids to glycerol-3-phosphate, primarily in the endoplasmic reticulum. The canonical pathway involves enzymes such as GPAT, AGPAT, PAP, and DGAT. McLelland et al. identified an alternative triglyceride biosynthesis pathway that can compensate when the canonical route is impaired, revealing redundancy in triglyceride production. This synthesis is critical for storing excess energy and preventing free fatty acid toxicity.
Lipid Droplet Formation and Storage
In simple terms: Newly made triglycerides are packed into lipid droplets, which act as cellular fat storage depots.
Triglycerides are stored in lipid droplets, organelles with a neutral lipid core surrounded by a phospholipid monolayer and associated proteins. Lipid droplet homeostasis is regulated by proteins such as LBP, which resists hepatic oxidative stress by modulating lipid droplet dynamics. ORP8 (OSBPL8) functions as a lipophagy receptor that mediates lipid droplet turnover, linking lipid droplets to autophagic degradation. Proper lipid droplet formation is essential for sequestering triglycerides and preventing lipotoxicity.
Lipolysis and Fatty Acid Mobilization
In simple terms: When energy is needed, triglycerides are broken down to release fatty acids.
Lipolysis is the hydrolysis of triglycerides into glycerol and free fatty acids. Adipose triglyceride lipase (ATGL/PNPLA2) catalyzes the initial and rate-limiting step of triglyceride hydrolysis. Transgenic mouse studies have shown that ATGL is crucial for both lipid and glucose homeostasis; its loss leads to excessive triglyceride accumulation and altered glucose metabolism. During fasting, Rab30 facilitates lipid homeostasis, likely by promoting lipid mobilization or remodeling.
Hormonal and Nuclear Receptor Regulation
In simple terms: Hormones and nuclear receptors adjust triglyceride levels according to the body's needs.
The farnesoid X receptor (FXR/NR1H4) is a master regulator of hepatic triglyceride and glucose homeostasis, controlling genes involved in lipid synthesis and transport. Angiopoietin-like 3 (ANGPTL3) regulates plasma triglyceride levels by inhibiting lipoprotein lipase; its inhibition lowers triglycerides and affects glucose homeostasis. These regulatory circuits ensure that triglyceride storage and mobilization adapt to nutritional and hormonal signals.
Lipophagy and Lipid Droplet Turnover
In simple terms: Cells can digest lipid droplets through autophagy to release stored fat.
Lipophagy is a selective form of autophagy that targets lipid droplets for degradation in lysosomes. ORP8 acts as a lipophagy receptor, mediating lipid droplet turnover and thereby contributing to triglyceride homeostasis. This pathway provides an alternative to cytosolic lipases for mobilizing triglycerides and is important during nutrient stress. Dysregulation of lipophagy can lead to lipid accumulation and cellular dysfunction.
Key Genes Involved in GO:0070328 triglyceride homeostasis
The following genes and proteins have been experimentally implicated in triglyceride homeostasis (GO:0070328) according to the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNPLA2 (ATGL) | Rate-limiting enzyme for triglyceride hydrolysis | Transgenic mouse models show altered lipid and glucose homeostasis |
| ANGPTL3 | Inhibits lipoprotein lipase; regulates plasma triglycerides | Target for lowering triglycerides and modulating glucose homeostasis |
| NR1H4 (FXR) | Master regulator of hepatic triglyceride and glucose homeostasis | Nuclear receptor controlling lipid and glucose gene programs |
| OSBPL8 (ORP8) | Lipophagy receptor mediating lipid droplet turnover | Links autophagy to triglyceride mobilization |
| Rab30 | Facilitates lipid homeostasis during fasting | Small GTPase involved in fasting-responsive lipid regulation |
| LBP | Regulates lipid droplet homeostasis and resists hepatic oxidative stress | Inflammation-related protein with lipid droplet functions |
| DGAT1/2 | Catalyze the final step of triglyceride synthesis (canonical pathway) | Targets for modulating triglyceride storage |
| GPAT | Catalyzes the first step of glycerolipid synthesis | Enzyme in the canonical triglyceride biosynthesis pathway |
| AGPAT | Acylates lysophosphatidic acid in triglyceride synthesis | Enzyme in the canonical triglyceride biosynthesis pathway |
| PAP | Dephosphorylates phosphatidic acid in triglyceride synthesis | Enzyme in the canonical triglyceride biosynthesis pathway |
| CGI-58 | Activates ATGL for lipolysis | Co-activator of triglyceride hydrolysis |
| G0S2 | Inhibits ATGL activity | Regulator of lipolysis |
| HSL (LIPE) | Hydrolyzes diacylglycerols during lipolysis | Enzyme in the lipolytic cascade |
| MGL (MGLL) | Hydrolyzes monoacylglycerols during lipolysis | Enzyme in the lipolytic cascade |
| FSP27 (CIDEC) | Promotes lipid droplet enlargement and storage | Lipid droplet-associated protein |
| PLIN1 | Coats lipid droplets and regulates lipolysis | Lipid droplet surface protein |
| LPL | Hydrolyzes plasma triglycerides for tissue uptake | Target of ANGPTL3 inhibition |
| INSIG | Regulates SREBP processing and lipid synthesis | Indirect regulator of triglyceride homeostasis |
How Is triglyceride homeostasis Regulated?
Triglyceride homeostasis is regulated at multiple levels. Nuclear receptors such as FXR (NR1H4) transcriptionally control genes involved in hepatic triglyceride and glucose metabolism. Hormonal signals, including angiopoietin-like proteins like ANGPTL3, modulate lipoprotein lipase activity and thus plasma triglyceride clearance. Nutritional status, particularly fasting, induces proteins such as Rab30 to facilitate lipid homeostasis. Post-translational regulation of lipases, including ATGL activation by CGI-58 and inhibition by G0S2, provides rapid control of lipolysis. Additionally, lipophagy mediated by ORP8 offers a lysosomal route for lipid droplet turnover, which is responsive to cellular stress and nutrient availability. Together, these mechanisms ensure that triglyceride levels are maintained within a narrow physiological range.
triglyceride homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPLA2 (ATGL) | Neutral lipid storage disease, insulin resistance | Knockout mouse, point-mutation knock-in |
| ANGPTL3 | Hypertriglyceridemia, diabetes | Overexpression and knockout models |
| NR1H4 (FXR) | Hepatic steatosis, cholestasis | Liver-specific knockout, agonist treatment |
| OSBPL8 (ORP8) | Lipid droplet accumulation, lipophagy defects | Knockout and tagged knock-in for imaging |
| LBP | Hepatic oxidative stress, steatosis | Knockout and overexpression in liver cells |
Metabolic Syndrome and Insulin Resistance
Dysregulation of triglyceride homeostasis is a hallmark of metabolic syndrome and insulin resistance. Elevated plasma triglycerides and ectopic lipid accumulation contribute to impaired insulin signaling. The triglyceride-glucose (TyG) index, a surrogate marker combining fasting triglycerides and glucose, is used to predict insulin resistance and diabetic nephropathy. FXR and ANGPTL3 are key regulators linking triglyceride metabolism to glucose homeostasis, making them attractive therapeutic targets.
Hepatic Steatosis and Oxidative Stress
Excessive hepatic triglyceride accumulation leads to steatosis, which can progress to steatohepatitis. LBP resists hepatic oxidative stress by regulating lipid droplet homeostasis, suggesting a protective role in liver lipid metabolism. FXR activation influences hepatic triglyceride levels and may protect against steatosis. Alternative triglyceride biosynthesis pathways may also contribute to lipid accumulation when canonical pathways are overwhelmed.
Diabetes and Diabetic Nephropathy
Impaired triglyceride homeostasis is closely linked to diabetes and its complications. ANGPTL3 affects both triglyceride regulation and glucose homeostasis, and its inhibition may have beneficial metabolic effects. The TyG index predicts diabetic nephropathy, underscoring the clinical relevance of triglyceride-glucose interplay. ATGL deficiency in mice alters glucose homeostasis, demonstrating a direct link between lipolysis and glucose metabolism.
Lipid Droplet-Related Disorders
Defects in lipid droplet turnover can cause lipotoxicity and cellular dysfunction. ORP8-mediated lipophagy is important for lipid droplet degradation; its dysfunction may lead to triglyceride accumulation. Rab30 facilitates lipid homeostasis during fasting, and its loss could impair the response to nutrient deprivation. Understanding these mechanisms may reveal therapeutic strategies for lipid storage disorders.
From triglyceride homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for triglyceride hydrolysis? | Knockout (e.g., PNPLA2 KO) |
| Does a specific mutation alter enzyme activity? | Point-mutation knock-in |
| How does a protein localize to lipid droplets? | Tagged knock-in (e.g., GFP-ORP8) |
| Does overexpression of a gene reduce plasma triglycerides? | Overexpression (e.g., ANGPTL3) |
| What is the role of a gene in fasting-induced lipid remodeling? | Knockout (e.g., Rab30 KO) |
| Does a nuclear receptor regulate triglyceride genes? | Knockout and agonist treatment (e.g., FXR) |
How to Study the triglyceride homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Triglyceride species and abundance | Quantify changes in triglyceride homeostasis |
| Enzymatic assay | Triglyceride concentration | Plasma or cell lysate triglyceride measurement |
| Live-cell imaging | Lipid droplet dynamics | Visualize lipid droplet turnover and lipophagy |
| CRISPR knockout | Gene function loss | Test requirement of a gene for triglyceride homeostasis |
| Transgenic overexpression | Gain-of-function effects | Assess impact on plasma triglycerides |
| RNA-seq | Transcriptional changes | Identify genes regulated by FXR or other factors |
| Western blot | Protein expression and modification | Validate knockout or overexpression |
| Co-immunoprecipitation | Protein-protein interactions | Study ATGL-CGI-58 or ORP8 complexes |
Lipidomics and Triglyceride Quantification
Mass spectrometry-based lipidomics enables comprehensive measurement of triglyceride species in cells and tissues. This method is essential for assessing changes in triglyceride homeostasis following genetic manipulation. Triglyceride levels can also be measured enzymatically in plasma or cell lysates.
Live-Cell Imaging of Lipid Droplets
Fluorescent dyes (e.g., BODIPY) and tagged lipid droplet proteins allow real-time visualization of lipid droplet dynamics. Tagged knock-in of proteins such as ORP8 can reveal their localization and turnover during lipophagy. Imaging is critical for understanding how proteins regulate lipid droplet size, number, and motility.
Genetic and Transgenic Models
Knockout, knock-in, and transgenic mice are used to test the causal role of genes in triglyceride homeostasis. For example, ATGL transgenic mice have clarified its role in lipid and glucose homeostasis. ANGPTL3 and FXR models have provided insights into triglyceride regulation and metabolic disease.
CRISPR Screening and Functional Genomics
CRISPR-based screens can identify novel regulators of triglyceride homeostasis by perturbing genes and measuring lipid accumulation. Such screens have the potential to uncover alternative pathways and compensatory mechanisms. Combined with bioinformatics, these approaches accelerate target discovery in metabolic research.
How CRISPR Can Be Used to Study GO:0070328 triglyceride homeostasis
Knockout
CRISPR knockout is used to delete genes such as PNPLA2, Rab30, or OSBPL8 to test their requirement for triglyceride homeostasis. Knockout models can reveal whether a gene is essential for lipid mobilization or storage. For example, ATGL knockout mice accumulate triglycerides and show altered glucose homeostasis.
Point Mutation
Point-mutation knock-in allows precise modification of catalytic residues or regulatory sites. This approach can dissect enzyme mechanisms, such as the catalytic activity of ATGL or the lipophagy receptor function of ORP8. Point mutants help distinguish between enzymatic and scaffolding functions.
Knock-in
Knock-in of tags (e.g., GFP, HA) enables visualization and purification of endogenous proteins involved in triglyceride homeostasis. Tagged ORP8 knock-in can be used to track lipid droplet turnover in live cells. Knock-in of disease-associated mutations can model human lipid disorders.
Overexpression
Overexpression of genes such as ANGPTL3 or LBP can test gain-of-function effects on triglyceride levels. Overexpression models are useful for studying dose-dependent regulation of triglyceride homeostasis. They complement knockout studies to establish causality.
How EDITGENE Supports triglyceride homeostasis Research
Researchers studying triglyceride homeostasis-related genes often need to determine whether a candidate gene is causally involved in lipid regulation or merely correlated with metabolic changes. CRISPR-based models provide the gold standard for establishing causality by enabling precise genetic perturbations in relevant cell types and animal models.
Contact EDITGENE today to design your custom CRISPR model for triglyceride homeostasis research.
Frequently Asked Questions About triglyceride homeostasis
What is triglyceride homeostasis?
Triglyceride homeostasis (GO:0070328) is the biological process that maintains physiological triglyceride levels by balancing synthesis, storage in lipid droplets, and lipolysis.
What genes are involved in triglyceride homeostasis?
Key genes include PNPLA2 (ATGL), ANGPTL3, NR1H4 (FXR), OSBPL8 (ORP8), Rab30, LBP, and enzymes of the DGAT/GPAT pathways.
How is triglyceride homeostasis regulated?
It is regulated by nuclear receptors such as FXR, hormones like ANGPTL3, fasting-induced proteins like Rab30, and post-translational control of lipases.
What diseases are linked to triglyceride homeostasis?
Dysregulation is linked to hepatic steatosis, insulin resistance, diabetes, diabetic nephropathy, and lipid storage disorders.
What is the role of ATGL in triglyceride homeostasis?
ATGL (PNPLA2) catalyzes the rate-limiting step of triglyceride hydrolysis and is essential for lipid and glucose homeostasis.
How does FXR regulate triglyceride homeostasis?
FXR (NR1H4) is a master regulator of hepatic triglyceride and glucose homeostasis, controlling gene expression programs.
What is the triglyceride-glucose index?
The TyG index is a surrogate marker of insulin resistance calculated from fasting triglycerides and glucose, and it predicts diabetic nephropathy.
What is lipophagy and how does it relate to triglyceride homeostasis?
Lipophagy is autophagic degradation of lipid droplets; ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover.
How can CRISPR be used to study triglyceride homeostasis?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of genes involved in triglyceride metabolism.
What methods are used to measure triglyceride homeostasis?
Lipidomics, enzymatic assays, live-cell imaging, RNA-seq, and CRISPR screens are commonly used.
Conclusion
Triglyceride homeostasis (GO:0070328) is a fundamental biological process that balances lipid storage and mobilization to maintain metabolic health. Dysregulation of this process contributes to prevalent diseases including steatosis, insulin resistance, and diabetes. Research using CRISPR models and advanced omics continues to uncover new regulators and therapeutic targets. EDITGENE provides comprehensive CRISPR services to accelerate discovery in this field.
References
- 1. McLelland GL et al.. 2023. Identification of an alternative triglyceride biosynthesis pathway.. Nature 621(7977):171-178 PMID: 37648867
- 2. Trites MJ et al.. 2019. The role of adipose triglyceride lipase in lipid and glucose homeostasis: lessons from transgenic mice.. Lipids Health Dis 18(1):204 PMID: 31757217
- 3. Zhang Q et al.. 2024. Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis.. Nat Commun 15(1):3213 PMID: 38615060
- 4. Christopoulou E et al.. 2019. Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes.. Dis Markers 2019:6578327 PMID: 30944669
- 5. Jiao Y et al.. 2015. Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis.. Acta Pharmacol Sin 36(1):44-50 PMID: 25500875
- 6. Smith DM et al.. 2024. Rab30 facilitates lipid homeostasis during fasting.. Nat Commun 15(1):4469 PMID: 38796472
- 7. Khan S et al.. 2024. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.. J Pak Med Assoc 74(5):862-867 PMID: 38783431
- 8. Pu M et al.. 2023. ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover.. Protein Cell 14(9):653-667 PMID: 37707322
